دکتر علی سعیدی بروجنی
Department of Medical Immunology, School of Medicine, Abadan University of Medical Sciences, Abadan, Iran
معرفی
استان
خوزستان
شهر
آبادان
سمتهای علمی و اجرایی علی سعیدی بروجنی در مجلات و ژورنال‌های معتبر ایران
- مجله تحقیقات بهداشتی و پزشکی (دبیر علمی)
سمتهای علمی و اجرایی علی سعیدی بروجنی در کنفرانس ها و نشستهای معتبر ایران
- دانشکده علوم پزشکی و خدمات بهداشتی درمانی آبادان (عضو هیات علمی)
مقالات بین المللی علی سعیدی بروجنی
"Tranilast as an Adjunctive Therapy in Hospitalized Patients with Severe COVID- 19: A Randomized Controlled Trial", Elsevier BV, (2022), Vol 53, No 4: 368-377
"Evaluating serum levels of interleukin-8 and interleukin-17 in patients with COVID-19 and their correlation with disease severity", Maad Rayan Publishing Company, (2022), Vol , No :
"Efficacy of a Low Dose of Melatonin as an Adjunctive Therapy in Hospitalized Patients with COVID-19: A Randomized, Double-blind Clinical Trial", Elsevier BV, (2022), Vol 53, No 1: 79-85
"Bromhexine is a potential drug for COVID-19; From hypothesis to clinical trials", Central Research Institute for Epidemiology, (2022), Vol 67, No 2: 126-132
"Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19", Informa UK Limited, (2021), Vol 43, No 3: 247-258
"miRNA-223 as a regulator of inflammation and NLRP3 inflammasome, the main fragments in the puzzle of immunopathogenesis of different inflammatory diseases and COVID-19", Springer Science and Business Media LLC, (2021), Vol 394, No 11: 2187-2195
"Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19?", Springer Science and Business Media LLC, (2021), Vol 394, No 5: 997-1001
"COVID-19 Pandemic along with Pandemic of Lifestyle-Associated Diseases Victimizes Patients in an Inflammation Context!", S. Karger AG, (2020), Vol 3, No 2: 55-57
"COVID‐19: A Case for Inhibiting NLRP3 Inflammasome, Suppression of Inflammation with Curcumin?", Wiley, (2020), Vol 128, No 1: 37-45
"Survivin as a diagnostic and therapeutic marker for thyroid cancer", Elsevier BV, (2019), Vol 215, No 4: 619-625
"MicroRNA-122 in patients with hepatitis B and hepatitis B virus-associated hepatocellular carcinoma", AME Publishing Company, (2019), Vol 10, No 4: 789-796
"Phytotherapy of nephrotoxicity-induced by cancer drugs: an
updated review", Maad Rayan Publishing Company, (2017), Vol 6, No 3: 254-263
"New Methods in Treatment of Renal Failure in Patients with Multiple Myeloma : A Review with Immunological Approach", Medi + World International, (2017), Vol 15, No 7: 95-103
"A new approach for treatment of type 1 diabetes: Phytotherapy and phytopharmacology of regulatory T cells", Maad Rayan Publishing Company, (2017), Vol 6, No 3: 158-163